SenoRx settles with Suros
This article was originally published in The Gray Sheet
Executive Summary
Firm agrees to remove the transverse slot from the cutter of its EnCor breast biopsy device without admission of liability or payments to resolve a patent dispute with Suros Surgical Systems. To avoid further litigation, which has been ongoing since Suros filed suit in the U.S. District Court for the Southern District of Indiana in February 2005, the technology, in its original form, cannot be sold after Oct. 31, 2006. The modification will have no impact on the EnCor device, SenoRx maintains...